var title_f34_21_35152="Classic Kaposi sarcoma - patches and plaques";
var content_f34_21_35152=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F81468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F81468&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Classic Kaposi sarcoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple red-brown patches and plaques are present on the lower leg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35152=[""].join("\n");
var outline_f34_21_35152=null;
var title_f34_21_35153="Physiologic bow-legs";
var content_f34_21_35153=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F73946&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F73946&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Physiologic bow-legs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 246px; height: 396px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Examination of the child with physiologic bowing shows symmetric bowing throughout the tibia and internal tibial torsion, which is often more noticeable with walking.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Schoenecker PL, Rich MM. The Lower Extremity. In: Lovell and Winter's Pediatric Orthopaedics, 6th ed, Morrissy RT, Weinstein SL (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Willims &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35153=[""].join("\n");
var outline_f34_21_35153=null;
var title_f34_21_35154="Apical 2C echo MAC";
var content_f34_21_35154=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F86970&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F86970&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Apical two chamber view of the left ventricle and mitral valve",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 373px; height: 413px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mitral annular calcification (MAC) is seen as a bright echodense&nbsp;structure&nbsp;along the posterior mitral valve annulus as calcium is a dense ultrasound reflector. In the lower portion of the image, there is absence of ultrasound penetration in the far field distal to the MAC&nbsp;due to acoustic shadowing. With severe acoustic shadowing, the left atrium may be obscured, making it difficult to identify and quantify mitral regurgitation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Rosario V Freeman, MD, MS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35154=[""].join("\n");
var outline_f34_21_35154=null;
var title_f34_21_35155="Dermatitis herpetiformis knee";
var content_f34_21_35155=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86749&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86749&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dermatitis herpetiformis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous papules and vesicles are present on the knee.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35155=[""].join("\n");
var outline_f34_21_35155=null;
var title_f34_21_35156="Edrophonium: Drug information";
var content_f34_21_35156=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Edrophonium: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/37/596?source=see_link\">",
"    see \"Edrophonium: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F164242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Enlon&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F164243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Enlon&reg;;",
"     </li>",
"     <li>",
"      Tensilon&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F164261\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Acetylcholinesterase Inhibitor;",
"     </li>",
"     <li>",
"      Antidote;",
"     </li>",
"     <li>",
"      Diagnostic Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F164246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Usually administered I.V., however, if not possible, I.M. or SubQ may be used.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Diagnosis of Myasthenia gravis:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.V.:",
"     </i>",
"     2 mg test dose administered over 15-30 seconds; 8 mg given 45 seconds later if no response is seen. Test dose may be repeated after 30 minutes.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      I.M.:",
"     </i>",
"     Initial: 10 mg; if no cholinergic reaction occurs, give 2 mg 30 minutes later to rule out false-negative reaction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Titration of oral anticholinesterase therapy:",
"     </b>",
"     1-2 mg given 1 hour after oral dose of anticholinesterase; if strength improves, an increase in neostigmine or pyridostigmine dose is indicated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Differentiation of cholinergic from myasthenic crisis:",
"     </b>",
"     I.V.: 1 mg; may repeat after 1 minute.",
"     <b>",
"      Note:",
"     </b>",
"     Intubation and controlled ventilation may be required if patient has cholinergic crisis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Reversal of nondepolarizing neuromuscular blocking agents (neostigmine with atropine usually preferred):",
"     </b>",
"     I.V.: 10 mg over 30-45 seconds; may repeat every 5-10 minutes up to 40 mg.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Termination of paroxysmal atrial tachycardia:",
"     </b>",
"     I.V. rapid injection: 5-10 mg",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F164254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/37/596?source=see_link\">",
"      see \"Edrophonium: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Usually administered I.V., however, if not possible, I.M. or SubQ may be used:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Infants:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: 0.5-1 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.V.: Initial: 0.1 mg, followed by 0.4 mg if no response; total dose = 0.5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Children:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Diagnosis:",
"     </b>",
"     Initial: 0.04 mg/kg over 1 minute followed by 0.16 mg/kg if no response, to a maximum total dose of 5 mg for children &lt;34 kg, or 10 mg for children &gt;34 kg",
"     <b>",
"      or",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Alternative dosing (manufacturer's recommendation):",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &le;34 kg: 1 mg; if no response after 45 seconds, repeat dosage in 1 mg increments every 30-45 seconds, up to a total of 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;34 kg: 2 mg; if no response after 45 seconds, repeat dosage in 1 mg increments every 30-45 seconds, up to a total of 10 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &lt;34 kg: 1 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     &gt;34 kg: 5 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Titration of oral anticholinesterase therapy:",
"     </b>",
"     0.04 mg/kg once given 1 hour after oral intake of the drug being used in treatment. If strength improves, an increase in neostigmine or pyridostigmine dose is indicated.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F164247\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F164248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dose may need to be reduced in patients with chronic renal failure.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15822397\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F164225\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution, as chloride:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Enlon&reg;: 10 mg/mL (15 mL) [contains natural rubber/natural latex in packaging, sodium sulfite]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F164211\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F164228\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Edrophonium is administered by direct I.V. injection; see Dosage",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F164267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Heparin, hydrocortisone sodium succinate, potassium chloride, vitamin B complex with C.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F164227\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Diagnosis of myasthenia gravis; differentiation of cholinergic crises from myasthenia crises; reversal of nondepolarizing neuromuscular blockers",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F164259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Arrhythmias (especially bradycardia), AV block, carbon monoxide decreased, cardiac arrest, ECG changes (nonspecific), flushing, hypotension, nodal rhythm, syncope, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Convulsions, dizziness, drowsiness, dysarthria, dysphonia, headache, loss of consciousness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Skin rash, thrombophlebitis (I.V.), urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Diarrhea, dysphagia, flatulence, hyperperistalsis, nausea, salivation, stomach cramps, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary urgency",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgias, fasciculations, muscle cramps, spasms, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Lacrimation, small pupils",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchiolar constriction, bronchospasm, dyspnea, bronchial secretions increased, laryngospasm, respiratory arrest, respiratory depression, respiratory muscle paralysis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, anaphylaxis, diaphoresis increased",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F164231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to edrophonium, sulfites, or any component of the formulation; GI or GU obstruction",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F164215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cholinergic crisis: Overdosage can cause cholinergic crisis which may be fatal.  Atropine should always be readily available as an antagonist and for treatment of cholinergic reactions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Arrhythmias: Use with caution in patients with cardiac arrhythmias (eg, bradyarrhythmias).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Use with caution in patients with bronchial asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis:  Avoid use in myasthenia gravis; may exacerbate muscular weakness.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiac glycosides: Use with caution in patients receiving a cardiac glycoside; may enhance AV block.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sodium sulfite: Products may contain sodium sulfite.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299253\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F164219\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Acetylcholinesterase Inhibitors may enhance the bradycardic effect of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholinergic Agonists: Acetylcholinesterase Inhibitors may enhance the adverse/toxic effect of Cholinergic Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the adverse/toxic effect of Acetylcholinesterase Inhibitors. Increased muscular weakness may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dipyridamole: May diminish the therapeutic effect of Acetylcholinesterase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents (Nondepolarizing): Acetylcholinesterase Inhibitors may diminish the neuromuscular-blocking effect of Neuromuscular-Blocking Agents (Nondepolarizing).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: Acetylcholinesterase Inhibitors may increase the serum concentration of Succinylcholine.  Management: Consider alternatives to this combination due to a risk of prolonged neuromuscular blockade.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F164250\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16323126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Enlon Injection)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10 mg/mL (15 mL): $50.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F164223\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Pre- and postinjection strength (cranial musculature is most useful); heart rate, respiratory rate, blood pressure",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F6038609\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Anticude (ES);",
"     </li>",
"     <li>",
"      Camsilon (GB)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F164214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits destruction of acetylcholine by acetylcholinesterase. This facilitates transmission of impulses across myoneural junction and results in increased cholinergic responses such as miosis, increased tonus of intestinal and skeletal muscles, bronchial and ureteral constriction, bradycardia, and increased salivary and sweat gland secretions.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F164230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: I.M.: 2-10 minutes; I.V.: 30-60 seconds",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: I.M.: 5-30 minutes: I.V.: 10 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : Adults: 1.1 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Adults: 1.2-2.4 hours; Anephric patients: 2.4-4.4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Adults: Primarily urine (67%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Azar I, Pham AN, Karamkekar, et al, &ldquo;The Heart Rate Following Edrophonium-Atropine and Edrophonium Glycopyrrolate Mixtures,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1983, 59(2):139-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35156/abstract-text/6869871/pubmed\" id=\"6869871\" target=\"_blank\">",
"        6869871",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cronnely R and Morris RB, &ldquo;Antagonism of Neuromuscular Blockade,&rdquo;",
"      <i>",
"       Br J Anaesth",
"      </i>",
"      , 1982, 54(2):183-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35156/abstract-text/7037027/pubmed\" id=\"7037027\" target=\"_blank\">",
"        7037027",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fisher DM, et al, &ldquo;Clinical Pharmacology of Edrophonium in Infants and Children,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1984, 61(4):428-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35156/abstract-text/6486504/pubmed\" id=\"6486504\" target=\"_blank\">",
"        6486504",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mokhlesi B, Leikin JB, Murray P, et al, &ldquo;Adult Toxicology in Critical Care: Part II: Specific Poisonings,&rdquo;",
"      <i>",
"       Chest",
"      </i>",
"      , 2003, 123(3):897-922.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35156/abstract-text/12628894/pubmed\" id=\"12628894\" target=\"_blank\">",
"        12628894",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rossen RN, Krikorian J, and Hancock EW, &ldquo;Ventricular Asystole After Edrophonium Chloride Administration,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1976, 235(10):1041-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35156/abstract-text/765513/pubmed\" id=\"765513\" target=\"_blank\">",
"        765513",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Youngberg JA, &ldquo;Cardiac Arrest Following Treatment of Paroxysmal Atrial Tachycardia With Edrophonium,&rdquo;",
"      <i>",
"       Anesthesiology",
"      </i>",
"      , 1979, 50(3):234-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35156/abstract-text/434509/pubmed\" id=\"434509\" target=\"_blank\">",
"        434509",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9403 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-23B01FB2C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35156=[""].join("\n");
var outline_f34_21_35156=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164242\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164243\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164261\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164246\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164254\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164247\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164248\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15822397\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164225\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164211\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164228\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164267\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164227\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164259\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164231\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164215\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299253\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164219\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164250\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16323126\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164223\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6038609\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164214\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164230\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9403\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9403|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?0/37/596?source=related_link\">",
"      Edrophonium: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_21_35157="Linagliptin: Drug information";
var content_f34_21_35157=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"39\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Linagliptin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?29/52/30532?source=see_link\">",
"    see \"Linagliptin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block spa drugH1Div\" id=\"F16339633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Special Alerts",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      FDA Investigating Unpublished Reports of Pancreatic Toxicity With Incretin Mimetic Drugs",
"     </span>",
"     <span class=\"collapsible-date\">",
"      March 2013",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       The Food and Drug Administration (FDA) is evaluating unpublished new findings that suggest an increased risk of pancreatitis and pancreatic duct metaplasia in patients with type 2 diabetes treated with incretin mimetics. These findings are based on pancreatic tissue samples taken from patients who died from unspecified causes. The FDA has requested these samples, as well as information on the methodology used to collect them, and will communicate its final conclusions and recommendations. Healthcare providers should continue to prescribe incretin mimetics according to the drug label recommendations and patients receiving incretin mimetics are advised to continue therapy as directed and to discuss any concerns with their healthcare provider.",
"      </p>",
"      <p style=\"text-indent:0em;margin-top:2em;\">",
"       Further information may be found at the following website:",
"       <a href=\"file://www.fda.gov/Drugs/DrugSafety/ucm343187.htm\" target=\"_blank\">",
"        file://www.fda.gov/Drugs/DrugSafety/ucm343187.htm",
"       </a>",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F12841258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Tradjenta&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F13259793\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Trajenta&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F12807899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antidiabetic Agent, Dipeptidyl Peptidase IV (DPP-IV) Inhibitor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F12817450\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Type 2 diabetes:",
"     </b>",
"     Oral: 5 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Concomitant use with insulin and/or insulin secretagogues (eg, sulfonylureas):",
"     </i>",
"     Reduced dose of insulin and/or insulin secretagogues may be needed.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F12817451\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F12817453\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F12817452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary.",
"     <b>",
"      Note:",
"     </b>",
"     Canadian labeling does not recommend use in severe hepatic impairment.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F12841259\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Tradjenta&trade;: 5 mg",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F12817462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F12807901\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Management of type 2 diabetes mellitus (noninsulin dependent, NIDDM) as an adjunct to diet and exercise as monotherapy or in combination with other antidiabetic agents",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F14198962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F12817422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%: Endocrine &amp; metabolic: Hypoglycemia (combined with metformin and/or sulfonylurea [15% to 23%]; monotherapy [&lt;1% to 7%]; metformin [&lt;1%], pioglitazone [&lt;1%])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Headache (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Hyperuricemia (3%), lipids increased (3%), triglycerides increased (2% to 3%), weight gain (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Constipation (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Genitourinary: Urinary tract infection (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Neuromuscular &amp; skeletal: Arthralgia (6%), back pain (6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Respiratory: Nasopharyngitis (6% to 7%), cough (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1% (Limited to important or life-threatening): Angioedema, hypersensitivity, pancreatitis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F12817411\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to linagliptin or any component of the formulation",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications: Use in type 1 diabetes mellitus or diabetic ketoacidosis",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F12817412\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Insulin: Concomitant use of insulin may increase the risk of hypoglycemia. Monitor blood glucose closely; dosage reduction of insulin may be required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Insulin secretagogues: Concomitant use of an insulin secretagogue (eg, sulfonylurea) may increase the risk of hypoglycemia. Monitor blood glucose closely; dosage reduction of secretagogues may be required.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Diabetic ketoacidosis (DKA): Linagliptin should not be used in patients with DKA due to lack of efficacy in this patient population.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Heart failure: Clinical trials included only a limited number of patients with heart failure (HF). No specific recommendations regarding this population are provided in the approved U.S. labeling (Canadian labeling recommends against use in this population).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Type 1 diabetes mellitus: Linagliptin should not be used in patients with type 1 diabetes mellitus (insulin dependent, IDDM) due to lack of efficacy in this patient population.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Patient education: Diabetes self-management education (DSME) is essential to maximize the effectiveness of therapy.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299603\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP3A4 (major), P-glycoprotein;",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F12858794\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: DPP-IV Inhibitors may enhance the adverse/toxic effect of ACE Inhibitors. Specifically, the risk of angioedema may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Orally Inhaled): May diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May diminish the hypoglycemic effect of Antidiabetic Agents. In some instances, corticosteroid-mediated HPA axis suppression has led to episodes of acute adrenal crisis, which may manifest as enhanced hypoglycemia, particularly in the setting of insulin or other antidiabetic agent use.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP3A4 Inducers (Strong): May decrease the serum concentration of Linagliptin. Management: Strongly consider using an alternative to any strong CYP3A4 inducer in patients who are being treated with linagliptin. If this combination is used, monitor patients closely for evidence of reduced linagliptin effectiveness.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (CYP3A4 Inducers): May increase the metabolism of CYP3A4 Substrates. Management: Consider avoiding CYP3A4 inducing herbs in order to avoid therapeutic failure of the substrate. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypoglycemic Properties): May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: May enhance the adverse/toxic effect of other Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: May diminish the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Luteinizing Hormone-Releasing Hormone Analogs: May diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: May enhance the hypoglycemic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inducers: May decrease the serum concentration of Linagliptin. Management: Strongly consider using an alternative to any strong P-glycoprotein inducer in patients who are being treated with linagliptin. If this combination is used, monitor patients closely for evidence of reduced linagliptin effectiveness.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     P-glycoprotein/ABCB1 Inhibitors: May increase the serum concentration of P-glycoprotein/ABCB1 Substrates. P-glycoprotein inhibitors may also enhance the distribution of p-glycoprotein substrates to specific cells/tissues/organs where p-glycoprotein is present in large amounts (e.g., brain, T-lymphocytes, testes, etc.).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ritonavir: May increase the serum concentration of Linagliptin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents. Selective Serotonin Reuptake Inhibitors may increase the serum concentration of Hypoglycemic Agents. Management: Consider increased monitoring of glycemic control with concomitant use of a hypoglycemic agent and an SSRI. Dosage adjustments of the hypoglycemic agent may be necessary upon SSRI initiation or discontinuation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Somatropin: May diminish the hypoglycemic effect of Antidiabetic Agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiazide Diuretics: May diminish the therapeutic effect of Antidiabetic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F12817426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ethanol: Caution with ethanol (may cause hypoglycemia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herb/Nutraceutical: Herbs with hypoglycemic properties may enhance the hypoglycemic effect of linagliptin. This includes alfalfa, aloe, bilberry, bitter melon, burdock, celery, damiana, fenugreek, garcinia, garlic, ginger, ginseng (American), gymnema, marshmallow, stinging nettle.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F12817407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12817408\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies, except with doses that were also maternally  toxic.  Maternal hyperglycemia can be associated with adverse effects in the fetus, including macrosomia, neonatal hyperglycemia, and hyperbilirubinemia; the risk of congenital malformations is increased when the Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     is above the normal range. Diabetes can also be associated with adverse effects in the mother. Poorly-treated diabetes may cause end-organ damage that may in turn negatively affect obstetric outcomes. Physiologic glucose levels should be maintained prior to and during pregnancy to decrease the risk of adverse events in the mother and the fetus. Until additional safety and efficacy data are obtained, the use of oral agents is generally not recommended as routine management of GDM or type 2 diabetes mellitus during pregnancy. Insulin is the drug of choice for the control of diabetes mellitus during pregnancy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F12817409\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F12817410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if linagliptin is excreted in breast milk. The manufacturer recommends that caution be used if administered to breast-feeding women.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F12817440\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to food. Individualized medical nutrition therapy (MNT) based on ADA recommendations is an integral part of therapy.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322899\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Tradjenta Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5 mg (90): $870.11",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F12817464\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     , serum glucose",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F12817461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Recommendations for glycemic control in nonpregnant adults with diabetes (ADA, 2012):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     : &lt;7% (a more aggressive [&lt;6.5%] or less aggressive [&lt;8%] Hb A",
"     <sub>",
"      1c",
"     </sub>",
"     goal may be targeted based on patient-specific characteristics)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Preprandial capillary plasma glucose: 70-130 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Peak postprandial capillary blood glucose: &lt;180 mg/dL",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F13733206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Trajenta (AU, CH, CZ, DK, EE, GB, ID, NO, SE, SG);",
"     </li>",
"     <li>",
"      Trayenta (AR, BR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F12817429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Linagliptin inhibits dipeptidyl peptidase IV (DPP-IV) enzyme resulting in prolonged active incretin levels. Incretin hormones (eg, glucagon-like peptide-1 [GLP-1] and glucose-dependent insulinotropic polypeptide [GIP]) regulate glucose homeostasis by increasing insulin synthesis and release from pancreatic beta cells and decreasing glucagon secretion from pancreatic alpha cells. Decreased glucagon secretion results in decreased hepatic glucose production. Under normal physiologic circumstances, incretin hormones are released by the intestine throughout the day and levels are increased in response to a meal; incretin hormones are rapidly inactivated by the DPP-IV enzyme.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F12817431\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Rapid",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: Extensive",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: 70% to 80%; concentration dependent",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Not extensively metabolized",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: 30%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: Effective (therapeutic): ~12 hours; Terminal (DPP-IV saturable binding): &gt;100 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak: 1.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: 80% feces unchanged; 5% urine unchanged",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Diabetes Association, &ldquo;Standards of Medical Care in Diabetes Mellitus -- 2012,&rdquo;",
"      <i>",
"       Diabetes Care",
"      </i>",
"      , 2012, 35(Suppl 1):11-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35157/abstract-text/22187469/pubmed\" id=\"22187469\" target=\"_blank\">",
"        22187469",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, \"Canadian Diabetes Association 2008 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada,\"",
"      <i>",
"       Can J Diabetes",
"      </i>",
"      , 20078, 32(suppl 1):1-201.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Handelsman Y, Mechanick JI, Blonde L, et al, &ldquo;American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan,&rdquo;",
"      <i>",
"       Endocr Pract",
"      </i>",
"      , 2011, 17(Suppl 2):1-53.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35157/abstract-text/21474420/pubmed\" id=\"21474420\" target=\"_blank\">",
"        21474420",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kirkman M, Briscoe VJ, Clark N, et al, \"Diabetes in Older Adults: A Consensus Report,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012; doi: 10.1111/jgs.12035.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35157/abstract-text/23106132/pubmed\" id=\"23106132\" target=\"_blank\">",
"        23106132",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Qaseem A, Humphrey LL, Sweet DE, et al,&ldquo;Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline from the American College of Physicians,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2012, 156(3):218-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35157/abstract-text/22312141/pubmed\" id=\"22312141\" target=\"_blank\">",
"        22312141",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Scott LJ, \"Linagliptin: In Type 2 Diabetes Mellitus,\"",
"      <i>",
"       Drugs",
"      </i>",
"      , 2011, 71(5):611-24.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35157/abstract-text/21443284/pubmed\" id=\"21443284\" target=\"_blank\">",
"        21443284",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16490 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-4327E6E395-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35157=[""].join("\n");
var outline_f34_21_35157=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16339633\">",
"      Special Alerts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12841258\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13259793\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12807899\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817450\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817451\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817453\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817452\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12841259\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817462\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12807901\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14198962\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817422\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817411\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817412\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299603\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12858794\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817426\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817407\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817408\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817409\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817410\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817440\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322899\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817464\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817461\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13733206\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817429\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12817431\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16490\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16490|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?29/52/30532?source=related_link\">",
"      Linagliptin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_21_35158="Pediculosis pubis";
var content_f34_21_35158=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F55191&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F55191&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pediculosis pubis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 386px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous lice and nits located around the pubic hair.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of John T Crissey, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35158=[""].join("\n");
var outline_f34_21_35158=null;
var title_f34_21_35159="Pregnancy in women with congenital heart disease: Specific lesions";
var content_f34_21_35159=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pregnancy in women with congenital heart disease: Specific lesions",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/21/35159/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/21/35159/contributors\">",
"     Joseph K Perloff, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/21/35159/contributors\">",
"     Carol A Waksmonski, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/21/35159/contributors\">",
"     Michael R Foley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/21/35159/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/21/35159/contributors\">",
"     Thomas P Graham, Jr, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/21/35159/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/21/35159/contributors\">",
"     Heidi M Connolly, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?34/21/35159/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?34/21/35159/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?34/21/35159/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 28, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risks associated with pregnancy in women with congenital heart disease affect both the mother and her fetus. The obstetrician and cardiologist are therefore responsible for the welfare of two patients.",
"   </p>",
"   <p>",
"    The focus here is on management of pregnant women with specific congenital cardiac anomalies, both unrepaired and after reparative surgery. Other issues such as maternal risks, oxygen delivery, and management during labor and postpartum are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/7/29818?source=see_link\">",
"     \"Pregnancy in women with congenital heart disease: General principles\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Certain lesions such as coarctation of the aorta and Marfan syndrome are discussed elsewhere. Also covered separately are general cardiac issues concerning the management of arrhythmias, heart failure, and anticoagulation during pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/46/18153?source=see_link\">",
"     \"Anticoagulation during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14362?source=see_link\">",
"     \"Supraventricular arrhythmias during pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/31/7674?source=see_link\">",
"     \"Ventricular arrhythmias during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENERAL MATERNAL AND FETAL RISKS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reparative surgery has substantially increased the number of females with congenital heart disease who reach childbearing age. Successful operation before gestation is pivotal in reducing maternal and fetal risks. The risks of pregnancy after surgery are determined chiefly by the presence, type, and degree of cardiac and vascular residua and sequelae.",
"   </p>",
"   <p>",
"    The 2008 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines for the management of adults with congenital heart disease and the 2011 European Society of Cardiology (ESC) guidelines for management of cardiovascular disease during pregnancy included pregnancy recommendations for various congenital lesions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Women with congenital heart disease are advised to consult an adult congenital heart disease specialist before becoming pregnant. The management plan should include labor and the postpartum.",
"   </p>",
"   <p>",
"    In women with congenital heart disease, the risks of pregnancy to mother and fetus are related to the severity of the heart disease. These issues are described in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/7/29818?source=see_link&amp;anchor=H5#H5\">",
"     \"Pregnancy in women with congenital heart disease: General principles\", section on 'Major maternal cardiac risks'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/7/29818?source=see_link&amp;anchor=H26#H26\">",
"     \"Pregnancy in women with congenital heart disease: General principles\", section on 'Fetal risk'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of specific lesions to the fetus is discussed in appropriate sections below [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/3\">",
"     3",
"    </a>",
"    ]. The fetal risk of heritability of congenital heart disease is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/7/29818?source=see_link&amp;anchor=H31#H31\">",
"     \"Pregnancy in women with congenital heart disease: General principles\", section on 'Inheritance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     INTRACARDIAC SHUNTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major unoperated left-to-right intracardiac shunts that permit survival to childbearing age are ostium secundum atrial septal defect (ASD) (",
"    <a class=\"graphic graphic_figure graphicRef72533 \" href=\"mobipreview.htm?23/17/23826\">",
"     figure 1",
"    </a>",
"    ) and ventricular septal defect (VSD) (",
"    <a class=\"graphic graphic_figure graphicRef52487 \" href=\"mobipreview.htm?12/0/12290\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Ostium secundum ASD",
"    </span>",
"    &nbsp;&mdash;&nbsp;Longevity in patients with an unoperated ostium secundum ASD spans the reproductive years. ASD is the most common repaired or unrepaired lesion in pregnant women with congenital heart disease. Issues related to pregnancy in women with ostium secundum ASD are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/0/25610?source=see_link\">",
"     \"Management of atrial septal defects in adults\"",
"    </a>",
"    .).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Ventricular septal defect",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy in women with repaired or unrepaired VSDs are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/52/14154?source=see_link&amp;anchor=H21905021#H21905021\">",
"     \"Ventricular septal defect in adults\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Atrioventricular septal defect",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy in women with atrioventricular septal defects is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/52/14154?source=see_link&amp;anchor=H568452#H568452\">",
"     \"Ventricular septal defect in adults\", section on 'Pregnancy with AVSD'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Cyanotic congenital heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cyanotic congenital lesions include unrepaired tetralogy of Fallot, pulmonary atresia with aorto-pulmonary collaterals, some single ventricular lesions, tricuspid atresia, Ebstein's anomaly with right-to-left shunts via an ASD, and congenitally corrected transposition of the great arteries with VSD or ASD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A literature review reported the following complication rates during completed pregnancies (&gt;20 weeks gestation) among women with palliated or unrepaired cyanotic congenital heart disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maternal arrhythmias occurred in 3 of 63 pregnancies, heart failure in 14 of 74 pregnancies, and other cardiovascular events in 3 of 74 pregnancies.",
"     </li>",
"     <li>",
"      Preterm delivery occurred in 33 of 74 pregnancies (45 percent), fetal mortality in 9 of 74 pregnancies (12 percent), the peri-natal mortality rate was 4 percent (3 of 74 pregnancies), and the rate of recurrence of congenital heart disease of any type in offspring was 7 percent (5 of 68). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/7/29818?source=see_link&amp;anchor=H31#H31\">",
"       \"Pregnancy in women with congenital heart disease: General principles\", section on 'Inheritance'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The above data included only pregnancies that reached at least 20 weeks gestation. In a review of 96 pregnancies in 44 women with cyanotic congenital heart disease, the live birth rate was 43 percent, and was strongly related to both the hematocrit and arterial oxygen saturation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/4\">",
"     4",
"    </a>",
"    ]. A successful pregnancy was unlikely if the maternal hemoglobin was &ge; 20",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    (live birth rate of 8 percent) or the maternal arterial oxygen saturation was &le; 85 percent (live birth rate of 12 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     PATENT DUCTUS ARTERIOSUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy in women with a PDA is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33448?source=see_link&amp;anchor=H22#H22\">",
"     \"Management of patent ductus arteriosus\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     EISENMENGER SYNDROME",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eisenmenger syndrome can occur with unrepaired ASD, VSD, PDA, or more complex cardiac lesions when progressive pulmonary vascular disease leads to intracardiac shunt reversal or bidirectional shunting (",
"    <a class=\"graphic graphic_figure graphicRef70502 \" href=\"mobipreview.htm?33/8/33927\">",
"     figure 3",
"    </a>",
"    ). Regardless of etiology, pregnancy in the Eisenmenger syndrome is associated with major morbidity and mortality. Issues related to pregnancy in women with Eisenmenger syndrome are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/20/7496?source=see_link&amp;anchor=H6#H6\">",
"     \"Medical management of Eisenmenger syndrome\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     VALVULAR HEART DISEASE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Maternal and/or fetal risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association (with 2008 update) and the 2007 European Society of Cardiology guidelines for the management of valvular heart disease classified specific valve lesions and clinical settings as high or low maternal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    fetal risk according to the severity of the lesion and the presence or absence of symptoms based on the New York Heart Association (NYHA) classification (",
"    <a class=\"graphic graphic_table graphicRef52683 \" href=\"mobipreview.htm?3/2/3117\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/26/29097?source=see_link&amp;anchor=H9#H9\">",
"     \"Acquired heart disease and pregnancy\", section on 'Valvular heart disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with any of the following lesions were considered high risk [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/5\">",
"     5",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Severe aortic stenosis with or without symptoms (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/25/27032?source=see_link\">",
"       \"Pregnancy in women with a bicuspid aortic valve\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/25/27032?source=see_link&amp;anchor=H9#H9\">",
"       \"Pregnancy in women with a bicuspid aortic valve\", section on 'Bicuspid aortic stenosis'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      However, the CARPREG model found that even mild to moderate aortic stenosis was associated with increased risk because of medial disease of the ascending aorta (see below). An aortic valve area of &lt;1.5 cm",
"      <sup>",
"       2",
"      </sup>",
"      or peak gradient of &gt;30 mmHg predicts a 27 percent event rate. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/7/29818?source=see_link&amp;anchor=H11#H11\">",
"       \"Pregnancy in women with congenital heart disease: General principles\", section on 'CARPREG risk index'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Aortic regurgitation or mitral regurgitation with NYHA class III to IV symptoms (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/34/1577?source=see_link\">",
"       \"Management of heart failure in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Bicuspid aortic valves with aortic root dilatation (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/25/27032?source=see_link\">",
"       \"Pregnancy in women with a bicuspid aortic valve\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Any condition that results in LV dysfunction (LVEF &lt;40 percent). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/34/1577?source=see_link\">",
"       \"Management of heart failure in pregnancy\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Pulmonary hypertension. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/20/7496?source=see_link&amp;anchor=H6#H6\">",
"       \"Medical management of Eisenmenger syndrome\", section on 'Pregnancy'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Mechanical valves that require chronic anticoagulation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1882?source=see_link\">",
"       \"Management of pregnant women with prosthetic heart valves\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Marfan syndrome with or without aortic regurgitation. Risk stratification in patients with Marfan syndrome is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20262?source=see_link\">",
"       \"Pregnancy and Marfan syndrome\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, patients with the following conditions were considered at low risk:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Asymptomatic aortic stenosis with an LVEF &gt;50 percent and a mean gradient less than 25 mmHg (although the CARPREG model found that even mild to moderate aortic stenosis was associated with increased risk as noted above) (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/7/29818?source=see_link&amp;anchor=H11#H11\">",
"       \"Pregnancy in women with congenital heart disease: General principles\", section on 'CARPREG risk index'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Aortic regurgitation or mitral regurgitation with absent or mild symptoms (NYHA class I to II)",
"     </li>",
"     <li>",
"      Mild to moderate pulmonary valve stenosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pregnancy can also affect the intensity of murmurs. The gestational increase in blood volume and cardiac output accentuate the murmurs associated with stenotic valve lesions, while the fall in systemic vascular resistance serves to attenuate murmurs associated with regurgitant lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Pulmonary valve stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy in women with pulmonary valve stenosis is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/27/12727?source=see_link&amp;anchor=H7#H7\">",
"     \"Natural history and treatment of pulmonic stenosis\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Tetralogy of Fallot",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy in women with tetralogy of Fallot is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28794?source=see_link\">",
"     \"Overview of the management of tetralogy of Fallot\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Bicuspid aortic valve",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy in women with a bicuspid aortic valve is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/25/27032?source=see_link\">",
"     \"Pregnancy in women with a bicuspid aortic valve\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Prosthetic heart valves",
"    </span>",
"    &nbsp;&mdash;&nbsp;A major issue in women with mechanical heart valves is anticoagulation. The management of pregnant women with prosthetic heart valves is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1882?source=see_link&amp;anchor=H10#H10\">",
"     \"Management of pregnant women with prosthetic heart valves\", section on 'Anticoagulation during pregnancy for women with mechanical heart valves'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/46/18153?source=see_link\">",
"     \"Anticoagulation during pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     CONGENITAL AORTIC DISEASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy in women with coarctation of the aorta and aortopathy related a bicuspid aortic valve or Marfan syndrome are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20922?source=see_link&amp;anchor=H21#H21\">",
"     \"Management of coarctation of the aorta\", section on 'Pregnancy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/25/27032?source=see_link\">",
"     \"Pregnancy in women with a bicuspid aortic valve\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20262?source=see_link\">",
"     \"Pregnancy and Marfan syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     UNCOMMON CONGENITAL CARDIAC DEFECTS IN PREGNANT WOMEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several uncommon congenital cardiac defects that permit high probability of survival into reproductive age. Individuals with these lesions require individualized assessment by an expert in adult congenital heart disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Complete heart block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete heart block can be congenital or acquired. The congenital form, sometimes called the neonatal lupus syndrome, is presumed to result from trans-placental passage of maternal",
"    <span class=\"nowrap\">",
"     anti-Ro/SSA",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     anti-La/SSB",
"    </span>",
"    antibodies. Approximately 50 percent of patients with congenital complete heart block are female and anticipate survival into childbearing age. The management of pregnancy in such patients is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/8/10376?source=see_link&amp;anchor=H11#H11\">",
"     \"Congenital third degree (complete) atrioventricular block\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Ebstein's anomaly",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues related to pregnancy in women with Ebstein's anomaly are discussed separately (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/52/38729?source=see_link\">",
"     \"Ebstein's anomaly of the tricuspid valve\"",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Congenitally corrected transposition of the great arteries",
"    </span>",
"    &nbsp;&mdash;&nbsp;This malformation, also called L-transposition of the great arteries (L-TGA), or atrio-ventricular, ventriculo-arterial discordance, or double discordance, is characterized by inversion of the ventricles, which is countered (corrected) by ventriculo-great arterial discordance. The double discordance \"corrects\" the circulation because systemic venous blood moves from the right atrium to the pulmonary artery, but via a morphologic left ventricle; pulmonary venous blood moves from the left atrium to the aorta via a morphologic right ventricle. The long-term functional durability of a morphologic right ventricle in the subaortic systemic location is problematic, and high-degree heart block occurs at a rate of about 2 percent per year. Clinical manifestations and disease course are heterogeneous. Nearly all patients with L-TGA have associated anomalies such as systemic AV valve abnormality in 90 percent, VSD in most, and pulmonic stenosis (often subvalvular) in 40 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The vulnerability of the morphologic subaortic right ventricle to hemodynamic overload, the development of heart failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/7\">",
"     7",
"    </a>",
"    ], and the risk of heart block make pregnancy problematic. However, a literature review of studies published between 1985 and 2007 found the following complication rates during completed pregnancies (&gt;20 weeks gestation) among women with L-TGA [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      With respect to the mother, arrhythmias occurred in 3 of 84 pregnancies, heart failure in 6 of 84 pregnancies, and cardiovascular events in 2 of 84 pregnancies.",
"     </li>",
"     <li>",
"      With respect to the fetus, preterm delivery occurred in 7 of 78 pregnancies, fetal mortality in 1 of 78 pregnancies, perinatal mortality in 0 of 78 pregnancies, and recurrent congenital heart disease (of any type) in 1 of 28 pregnancies.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Data are not yet available regarding the degree of RV dysfunction that imposes a higher pregnancy risk in this patient population.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     D-Transposition of the great arteries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with complete transposition of the great arteries are reaching reproductive age because of operative intervention initially involving atrial switch repairs, such as the Mustard or Senning procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/8\">",
"     8",
"    </a>",
"    ]. Gestational risks after Mustard or Senning repairs are related chiefly to the functional status of the subaortic morphologic right ventricle, to the level of pulmonary arterial pressure, and to conduction and rhythm abnormalities.",
"   </p>",
"   <p>",
"    Since 1982, the arterial switch operation (Jatene) has been used increasingly to repair D-TGA in infancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Successful pregnancy has been reported among patients who have had successful arterial switch procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The above cited literature review disclosed the rates of complications during completed pregnancies (&gt;20 weeks gestation) among women with D-transposition (atrial switch repair except for three arterial switch patients) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maternal arrhythmias occurred in 27 of 173 pregnancies (15.6 percent), heart failure in 19 of 176 pregnancies (10.8 percent), and cardiovascular events in 4 of 178 pregnancies (2.2 percent). The rate of preeclampsia was higher than expected (10 percent versus 2 to 3 percent).",
"     </li>",
"     <li>",
"      With respect to the fetus, preterm delivery occurred in 43 of 126 pregnancies (34.1 percent), fetal mortality in 5 of 179 pregnancies (2.8 percent), perinatal mortality in 2 of 179 pregnancies (1.1 percent) and recurrent congenital heart disease (of any type) in offspring in 1 of 176 pregnancies (0.6 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The predictors of increased risk have not yet been defined, although the degree of systemic RV dysfunction may play an important role.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Single ventricle, unrepaired",
"    </span>",
"    &nbsp;&mdash;&nbsp;A single ventricle or univentricular heart is a complex congenital cardiac defect with anatomic features that are not amenable to a biventricular repair and include hypoplasia of one ventricle, atresia of an atrioventricular valve, double inlet ventricle, double outlet ventricle with a remote ventricular septal defect, or an unbalanced atrioventricular canal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/13\">",
"     13",
"    </a>",
"    ]. In the majority of cases, the ventricular compartment has features of a morphologic left ventricle, and incorporates at its base a rudimentary outlet chamber that gives rise to the aorta, whereas the pulmonary trunk originates from the main ventricular compartment. Unrepaired adult patients may have anatomy unsuitable for palliation, or were not felt to be repairable in childhood.",
"   </p>",
"   <p>",
"    Patients who reach adulthood have either pulmonary stenosis or pulmonary vascular disease that permits adequate, but not excessive pulmonary blood flow. There are a few reports of successful pregnancies with single ventricle and pulmonary stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/14-17\">",
"     14-17",
"    </a>",
"    ], but pulmonary vascular disease carries the expected high gestational risk associated with Eisenmenger syndrome. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Eisenmenger syndrome'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/20/7496?source=see_link&amp;anchor=H6#H6\">",
"     \"Medical management of Eisenmenger syndrome\", section on 'Pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Tricuspid atresia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tricuspid atresia is a variety of functionally single ventricle. In patients with tricuspid atresia, systemic venous return cannot reach the right ventricle directly because of an imperforate right atrioventricular (tricuspid) valve. Instead, systemic venous return traverses the atrial septum from a morphologic right atrium into a morphologic left atrium, and mixes with pulmonary venous return before crossing a solitary left atrioventricular (mitral) valve that connects the left atrium to the left ventricle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the usual form of tricuspid atresia, there is ventriculo-great arterial concordance (non-transposed). A restrictive ventricular septal defect constitutes subpulmonary stenosis. Sporadic unoperated survivals have been reported from the second through the fifth decades.",
"   </p>",
"   <p>",
"    Successful pregnancy is rare but not unknown in unrepaired tricuspid atresia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Normal pregnancies have been experienced after a successful Fontan procedure, but the risk of preterm delivery may be increased [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Repaired functional single ventricle",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy after repair of a functionally single ventricle is now a practical objective. The Fontan operation, a palliative procedure performed for patients with single ventricle, creates an atrial-dependent or caval-dependent circulation in series without a subpulmonary ventricle. A nearly twofold increase in cardiac index can be achieved with isotonic exercise [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The implication of these hemodynamic observations is that women who have undergone successful Fontan repairs and who have satisfactory systemic ventricular function and normal sinus rhythm may have adequate hemodynamic reserve to accommodate the physiologic burden of pregnancy. However, high rates of spontaneous abortion and preterm deliveries have been observed. These event rates suggest that the alteration in placental blood flow caused by Fontan physiology is not well tolerated by the fetus.",
"   </p>",
"   <p>",
"    Data are limited on pregnancy outcomes after a Fontan operation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/3,20,23\">",
"     3,20,23",
"    </a>",
"    ]. In a report from two United States centers of 33 pregnancies after a Fontan operation, there were 15 live births, 13 spontaneous abortions, and five elective abortions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/20\">",
"     20",
"    </a>",
"    ]. All of the mothers did well.",
"   </p>",
"   <p>",
"    The above cited literature review reported rates of complications during 25 completed (&gt;20 weeks gestation) pregnancies among women with Fontan repair for various types of functional single ventricle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?34/21/35159/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maternal arrhythmias occurred in four pregnancies, heart failure in one pregnancy, and cardiovascular events (myocardial infarction, stroke, cardiovascular mortality) in none.",
"     </li>",
"     <li>",
"      With respect to the fetus, preterm delivery occurred in seven pregnancies, fetal mortality in no pregnancy, perinatal mortality in one pregnancy and recurrent congenital heart disease (of any type) in one pregnancy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13204675\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pregnancy in congenital heart disease affects the mother and her fetus. The obstetrician and cardiologist are therefore responsible for the welfare of two patients. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General maternal and fetal risks'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Given the heterogeneity of diseases, individual assessment and appropriate counseling by an adult congenital heart disease specialist is recommended for women with congenital heart disease who are contemplating pregnancy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General maternal and fetal risks'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Reparative surgery has substantially increased the number of females with congenital heart disease who reach childbearing age. Successful operation before gestation is pivotal in reducing maternal and fetal risks. The risks of pregnancy after surgery are determined chiefly by the presence, type, and degree of cardiac and vascular residua and sequelae. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'General maternal and fetal risks'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/1\">",
"      Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 Guidelines for the Management of Adults with Congenital Heart Disease: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines for the management of adults with congenital heart disease). Circulation 2008; 118:2395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/2\">",
"      European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011; 32:3147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/3\">",
"      Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Outcome of pregnancy in women with congenital heart disease: a literature review. J Am Coll Cardiol 2007; 49:2303.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/4\">",
"      Presbitero P, Somerville J, Stone S, et al. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation 1994; 89:2673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/5\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/6\">",
"      Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/7\">",
"      Lam D, Cheitlin MD, Popper RW, Szarnicki RJ. Rapid development of biventricular heart failure in corrected transposition of the great arteries during pregnancy. Am Heart J 1988; 116:1111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/8\">",
"      Clarkson PM, Wilson NJ, Neutze JM, et al. Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol 1994; 24:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/9\">",
"      Jatene AD, Fontes VF, Souza LC, et al. Anatomic correction of transposition of the great arteries. J Thorac Cardiovasc Surg 1982; 83:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/10\">",
"      Losay J, Hougen TJ. Treatment of transposition of the great arteries. Curr Opin Cardiol 1997; 12:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/11\">",
"      Gutgesell HP, Massaro TA, Kron IL. The arterial switch operation for transposition of the great arteries in a consortium of university hospitals. Am J Cardiol 1994; 74:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/12\">",
"      Ploeg M, Drenthen W, van Dijk A, Pieper PG. Successful pregnancy after an arterial switch procedure for complete transposition of the great arteries. BJOG 2006; 113:243.",
"     </a>",
"    </li>",
"    <li>",
"     Perloff, JK. The Clinical Recognition of Congenital Heart Disease, 6th ed, Elsevier/Saunders, Philadelphia 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/14\">",
"      Baumann H, Schneider H, Drack G, et al. Pregnancy and delivery by caesarean section in a patient with transposition of the great arteries and single ventricle. Case report. Br J Obstet Gynaecol 1987; 94:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/15\">",
"      Leibbrandt G, M&uuml;nch U, Gander M. Two successful pregnancies in a patient with single ventricle and transposition of the great arteries. Int J Cardiol 1982; 1:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/16\">",
"      Fong J, Druzin M, Gimbel AA, Fisher J. Epidural anaesthesia for labour and caesarean section in a parturient with a single ventricle and transposition of the great arteries. Can J Anaesth 1990; 37:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/17\">",
"      Sumner D, Melville C, Smith CD, et al. Successful pregnancy in a patient with a single ventricle. Eur J Obstet Gynecol Reprod Biol 1992; 44:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/18\">",
"      Bitsch M, Johansen C, Wennevold A, Osler M. Eisenmenger's syndrome and pregnancy. Eur J Obstet Gynecol Reprod Biol 1988; 28:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/19\">",
"      Hatjis CG, Gibson M, Capeless EL, et al. Pregnancy in a patient with tricuspid atresia. Am J Obstet Gynecol 1983; 145:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/20\">",
"      Canobbio MM, Mair DD, van der Velde M, Koos BJ. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996; 28:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/21\">",
"      Lao TT, Sermer M, Colman JM. Pregnancy after the fontan procedure for tricuspid atresia. A case report. J Reprod Med 1996; 41:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/22\">",
"      Barber G, Di Sessa T, Child JS, et al. Hemodynamic responses to isolated increments in heart rate by atrial pacing after a Fontan procedure. Am Heart J 1988; 115:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?34/21/35159/abstract/23\">",
"      Drenthen W, Pieper PG, Roos-Hesselink JW, et al. Pregnancy and delivery in women after Fontan palliation. Heart 2006; 92:1290.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1415 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-194.187.108.93-5353394DC6-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35159=[""].join("\n");
var outline_f34_21_35159=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13204675\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENERAL MATERNAL AND FETAL RISKS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      INTRACARDIAC SHUNTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Ostium secundum ASD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Ventricular septal defect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Atrioventricular septal defect",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Cyanotic congenital heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      PATENT DUCTUS ARTERIOSUS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      EISENMENGER SYNDROME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      VALVULAR HEART DISEASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Maternal and/or fetal risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Pulmonary valve stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Tetralogy of Fallot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Bicuspid aortic valve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      CONGENITAL AORTIC DISEASE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      UNCOMMON CONGENITAL CARDIAC DEFECTS IN PREGNANT WOMEN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Complete heart block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Ebstein's anomaly",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Congenitally corrected transposition of the great arteries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      D-Transposition of the great arteries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Single ventricle, unrepaired",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Tricuspid atresia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Repaired functional single ventricle",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13204675\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/1415\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1415|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/17/23826\" title=\"figure 1\">",
"      Pathophysiology ASD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/0/12290\" title=\"figure 2\">",
"      Pathophysiology VSD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?33/8/33927\" title=\"figure 3\">",
"      Eisenmenger syndrome anatomy and physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/1415|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/2/3117\" title=\"table 1\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/26/29097?source=related_link\">",
"      Acquired heart disease and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/46/18153?source=related_link\">",
"      Anticoagulation during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/8/10376?source=related_link\">",
"      Congenital third degree (complete) atrioventricular block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/52/38729?source=related_link\">",
"      Ebstein's anomaly of the tricuspid valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/0/25610?source=related_link\">",
"      Management of atrial septal defects in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/27/20922?source=related_link\">",
"      Management of coarctation of the aorta",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/34/1577?source=related_link\">",
"      Management of heart failure in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/42/33448?source=related_link\">",
"      Management of patent ductus arteriosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/53/1882?source=related_link\">",
"      Management of pregnant women with prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/20/7496?source=related_link\">",
"      Medical management of Eisenmenger syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/27/12727?source=related_link\">",
"      Natural history and treatment of pulmonic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/7/28794?source=related_link\">",
"      Overview of the management of tetralogy of Fallot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/50/20262?source=related_link\">",
"      Pregnancy and Marfan syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/25/27032?source=related_link\">",
"      Pregnancy in women with a bicuspid aortic valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/7/29818?source=related_link\">",
"      Pregnancy in women with congenital heart disease: General principles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/1/14362?source=related_link\">",
"      Supraventricular arrhythmias during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/31/7674?source=related_link\">",
"      Ventricular arrhythmias during pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/52/14154?source=related_link\">",
"      Ventricular septal defect in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_21_35160="Mucocele - lower lip";
var content_f34_21_35160=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F70332%7EPEDS%2F75671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F70332%7EPEDS%2F75671&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucocele",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A transluscent papule is present on the mucosal surface of the lower lip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 540px\">",
"   <div class=\"ttl\">",
"    Mucoceles",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 520px; height: 371px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mucocele on the tongue of&nbsp;7-year-old (A and B) and lower lip of 8.5-year-old (C and D).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Martha Ann Keels, DDS, PhD, Duke Pediatric Dentistry.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35160=[""].join("\n");
var outline_f34_21_35160=null;
var title_f34_21_35161="Clozapine: Drug information";
var content_f34_21_35161=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Clozapine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?8/41/8854?source=see_link\">",
"    see \"Clozapine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/31/13817?source=see_link\">",
"    see \"Clozapine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708679\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F153952\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Clozaril&reg;;",
"     </li>",
"     <li>",
"      FazaClo&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F153953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Clozapine&reg;;",
"     </li>",
"     <li>",
"      Clozaril&reg;;",
"     </li>",
"     <li>",
"      Gen-Clozapine",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F153995\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antipsychotic Agent, Atypical",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F153957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Schizophrenia:",
"     </b>",
"     Initial: 12.5 mg once or twice daily; increased, as tolerated, in increments of 25-50 mg/day to a target dose of 300-450 mg/day after 2 weeks; may further titrate in increments not exceeding 100 mg and no more frequently than once or twice weekly. May require doses as high as 600-900 mg/day (maximum dose: 900 mg/day).",
"     <b>",
"      Note:",
"     </b>",
"     In some efficacy studies, total daily dosage was administered in 3 divided doses.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Suicidal behavior in schizophrenia or schizoaffective disorder:",
"     </b>",
"     Initial: 12.5 mg once or twice daily; increased, as tolerated, in increments of 25-50 mg/day to a target dose of 300-450 mg/day after 2 weeks; mean dose is ~300 mg/day (range: 12.5-900 mg); treatment duration 2 years then reassess need.",
"     <b>",
"      Note:",
"     </b>",
"     If no longer a suicide risk, may resume prior antipsychotic therapy after gradually tapering off clozapine over 1-2 weeks.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Termination of therapy",
"     </i>",
"     : If dosing is interrupted for &ge;48 hours, therapy must be reinitiated at 12.5-25 mg/day; may be increased more rapidly than with initial titration, unless cardiopulmonary arrest occurred during initial titration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     In the event of planned termination of clozapine, gradual reduction in dose over a 1- to 2-week period is recommended. If conditions warrant abrupt discontinuation (leukopenia), monitor patient for psychosis and cholinergic rebound (headache, nausea, vomiting, diarrhea).",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F153973\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/31/13817?source=see_link\">",
"      see \"Clozapine: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children and Adolescents: Childhood psychosis (unlabeled use): Oral: Initial: 12.5-25 mg/day; increase to a target dose of 25-400 mg/day (Kumra, 2008; Turetz, 1997)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F153958\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Schizophrenia: Oral: Experience in the elderly is limited; initial dose should be 12.5-25 mg/day; increase as tolerated by 25 mg/day to desired response. Elderly may require slower titration and daily increases may not be tolerated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Psychosis/agitation related to Alzheimer&rsquo;s dementia (unlabeled use): Oral: Initial: 12.5 mg/day; if necessary, gradually increase as tolerated not to exceed 75-100 mg/day (Rabins, 2007)",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15795891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied); use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15795892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling (has not been studied); use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F744545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Eosinophilia:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     U.S. labeling: Interrupt therapy for eosinophil count &gt;4000/mm",
"     <sup>",
"      3",
"     </sup>",
"     ; may resume therapy when eosinophil count &lt;3000/mm",
"     <sup>",
"      3",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Canadian labeling: Interrupt therapy for eosinophil count &gt;3000/mm",
"     <sup>",
"      3",
"     </sup>",
"     ; may resume therapy when eosinophil count &lt;1000/ mm",
"     <sup>",
"      3",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Moderate leukopenia or granulocytopenia (WBC &lt;3000/mm",
"     <sup>",
"      3",
"     </sup>",
"     and/or ANC &lt;1500/mm",
"     <sup>",
"      3",
"     </sup>",
"     ): Discontinue therapy; may rechallenge patient when WBC is &gt;3500/mm",
"     <sup>",
"      3",
"     </sup>",
"     and ANC is &gt;2000/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"     <b>",
"      Note:",
"     </b>",
"     Patient is at greater risk for developing agranulocytosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Severe leukopenia or granulocytopenia (WBC &lt;2000/mm",
"     <sup>",
"      3",
"     </sup>",
"     and/or ANC &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     [U.S. labeling] or ANC &lt;1500/mm",
"     <sup>",
"      3",
"     </sup>",
"     [Canadian labeling]): Discontinue therapy and do not rechallenge patient.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-right:0em;margin-top:0em;text-align:justify;\">",
"     Platelets &lt;50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Canadian labeling recommends discontinuing therapy",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F153928\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral: 25 mg, 50 mg, 100 mg, 200 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clozaril&reg;: 25 mg, 100 mg [scored]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, orally disintegrating, oral: 12.5 mg, 25 mg, 100 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     FazaClo&reg;: 12.5 mg [contains phenylalanine 0.87 mg/tablet; mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     FazaClo&reg;: 25 mg [contains phenylalanine 1.74 mg/tablet; mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     FazaClo&reg;: 100 mg [contains phenylalanine 6.96 mg/tablet; mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     FazaClo&reg;: 150 mg [contains phenylalanine 10.44 mg/tablet; mint flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     FazaClo&reg;: 200 mg [contains phenylalanine 13.92 mg/tablet; mint flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F153912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F16156266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     Versacloz&trade; oral suspension: FDA approved February 2013; anticipated availability currently unknown.  Consult prescribing information for additional information.",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11218426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      U.S.:",
"     </b>",
"     Clozaril&reg; is deemed to have a REMS program (approval pending from FDA). As a requirement of the REMS program, access to this medication is restricted.  Patient-specific registration is required to dispense clozapine. Information specific to each monitoring program is available from the individual manufacturers. If a patient is switched from one brand/manufacturer of clozapine to another, the patient must be entered into a new registry (must be completed by the prescriber and delivered to the dispensing pharmacy). Healthcare providers, including pharmacists dispensing clozapine, should verify the patient's hematological status and qualification to receive clozapine with all existing registries. The manufacturer of Clozaril&reg; requests that healthcare providers submit all WBC/ANC values following discontinuation of therapy to the Clozaril National Registry for all nonrechallengable patients until WBC is  &ge;3500/mm",
"     <sup>",
"      3",
"     </sup>",
"     and ANC is  &ge;2000/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Canada:",
"     </b>",
"     Currently, there are multiple manufacturers that distribute clozapine and each manufacturer has its own registry and distribution system. Patients must be registered in a database that includes their location, prescribing physician, testing laboratory, and dispensing pharmacist before using clozapine. Information specific to each monitoring program is available from the individual manufacturers.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F153932\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to food. Total daily dose may be divided into uneven doses with larger dose administered at bedtime.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Canadian labeling: Maintenance dosing &le;200 mg/day may be administered as single dose in the evening.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     Orally-disintegrating tablet: Should be removed from foil blister by peeling apart (do not push tablet through the foil). Remove immediately prior to use. Place tablet in mouth and allow to dissolve; swallow with saliva. If dosing requires splitting tablet, throw unused portion away.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F153931\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment-refractory schizophrenia; to reduce risk of recurrent suicidal behavior in schizophrenia or schizoaffective disorder",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F153991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Schizoaffective disorder, bipolar disorder, childhood psychosis, severe obsessive-compulsive disorder; psychosis/agitation related to Alzheimer&rsquo;s dementia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F154003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       CloZAPine may be confused with clonazePAM, cloNIDine, KlonoPIN&reg;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Clozaril&reg; may be confused with Clinoril&reg;, Colazal&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      BEERS Criteria medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This drug may be potentially inappropriate for use in geriatric patients (Quality of evidence - moderate; Strength of recommendation - strong).",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F153993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Tachycardia (25%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Drowsiness (39% to 46%), dizziness (19% to 27%), insomnia (2% to 20%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Sialorrhea (31% to 48%), weight gain (4% to 31%), constipation (14% to 25%),  nausea/vomiting (3% to 17%), abdominal discomfort/heartburn (4% to 14%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Hypotension (9%), syncope (6%), hypertension (4%), angina (1%), ECG changes (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (7%), fever (5%), agitation (4%), akinesia (4%), nightmares (4%), restlessness (4%), akathisia (3%), confusion (3%), seizure (3%), fatigue (2%), anxiety (1%), ataxia (1%), depression (1%), lethargy (1%), myoclonic jerks (1%), slurred speech (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Rash (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Xerostomia (6%), diarrhea (2%), anorexia (1%), throat discomfort (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary abnormalities (eg, abnormal ejaculation, retention, urgency, incontinence; 1% to 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Leukopenia (3%), agranulocytosis (1%), eosinophilia (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Liver function tests abnormal (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Tremor (6%), hypokinesia (4%), rigidity (3%), hyperkinesia (1%), weakness (1%), pain (1%), spasm (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Visual disturbances (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Dyspnea (1%), nasal congestion (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis (6%), tongue numbness (1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1%, postmarketing, and/or case reports (limited to important or life-threatening): Amentia, amnesia, anemia, arrhythmia (atrial or ventricular), aspiration, blurred vision, bradycardia, bronchitis, cardiomyopathy (usually dilated), cataplexy, CHF, cholestasis, CPK increased, cyanosis, delirium, delusions, dermatitis, diabetes mellitus, difficult urination, DVT, dysphagia, eczema, edema, EEG abnormal, erythema multiforme, ESR increased, fecal impaction, gastric ulcer, gastroenteritis, granulocytopenia, hallucinations, hematemesis, hepatitis, hypercholesterolemia (rare), hyperglycemia, hypersensitivity reaction, hypertriglyceridemia (rare), hyperuricemia, hyponatremia, hyperosmolar coma, hypothermia, impotence, interstitial nephritis (acute), intestinal obstruction, jaundice, ketoacidosis, loss of speech, metabolic syndrome (Lamberti, 2006), MI, mitral valve  insufficiency, myasthenia syndrome, mydriasis, myocarditis, narrow-angle glaucoma, neuroleptic malignant syndrome, obsessive compulsive symptoms, palpitations, pancreatitis (acute), paralytic ileus, paresthesia, Parkinsonism, pericardial effusion, pericarditis, periorbital edema, phlebitis, photosensitivity, pleural effusion, pneumonia, priapism, pruritus, psychosis exacerbated, pulmonary embolism, rectal bleeding, respiratory arrest, rhabdomyolysis, salivary gland swelling, sepsis, status epilepticus, stroke, Stevens-Johnson syndrome, tardive dyskinesia, thrombocytopenia, thrombocytosis, thromboembolism, thrombophlebitis, torsade de pointes, urticaria, vasculitis, weight loss, wheezing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F153935\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to clozapine or any component of the formulation; history of agranulocytosis or severe granulocytopenia with clozapine; uncontrolled epilepsy, severe central nervous system depression or comatose state; paralytic ileus; myeloproliferative disorders or use with other agents which have a well-known risk of agranulocytosis or bone marrow suppression",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Canadian labeling: Additional contraindications (not in U.S. labeling): Active hepatic disease associated with nausea, anorexia, or jaundice; progressive hepatic disease or hepatic failure; severe renal impairment; severe cardiac disease (eg, myocarditis); patients unable to undergo blood testing",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F153916\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Agranulocytosis:",
"     <b>",
"      [U.S. Boxed Warning]: Significant risk of potentially life-threatening agranulocytosis. Due to the significant risk of agranulocytosis, treatment should be reserved for patients who fail at least two trials of other primary medications for the treatment of schizophrenia (of adequate dose and duration) or for those at risk of reexperiencing suicidal behavior.",
"     </b>",
"     Therapy should not be initiated in patients with WBC &lt;3500 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     or  ANC &lt;2000 cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ,  a history of myeloproliferative disorder, or clozapine -induced agranulocytosis or granulocytopenia. WBC testing should occur periodically on an on-going basis (see prescribing information for monitoring details) to ensure that acceptable WBC/ANC counts are maintained. Initial episodes of moderate leukopenia or granulopoietic suppression confer up to a 12-fold increased risk for subsequent episodes of agranulocytosis. WBCs must be monitored weekly for at least  4 weeks after therapy discontinuation or until WBC is &ge;3500/mm",
"     <sup>",
"      3",
"     </sup>",
"     and ANC is  &ge;2000/mm",
"     <sup>",
"      3",
"     </sup>",
"     . Use with caution in patients receiving other marrow suppressive agents. Eosinophilia has been reported to occur with clozapine. Interrupt therapy for eosinophil count &gt;4000/mm",
"     <sup>",
"      3",
"     </sup>",
"     . May resume therapy when eosinophil count &lt;3000/mm",
"     <sup>",
"      3",
"     </sup>",
"     . (",
"     <b>",
"      Note:",
"     </b>",
"     The Canadian labeling recommends discontinuing therapy for eosinophil count &gt;3000/mm",
"     <sup>",
"      3",
"     </sup>",
"     ; may resume therapy when eosinophil count &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     ). The restricted distribution system ensures appropriate WBC and ANC monitoring.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinergic effects: May cause anticholinergic effects (constipation, xerostomia, blurred vision, urinary retention); use with caution in patients with decreased gastrointestinal motility, paralytic ileus, urinary retention, BPH, xerostomia, or visual problems.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cerebrovascular effects: An increased incidence of cerebrovascular effects (eg, transient ischemic attack, stroke), including fatalities, has been reported in placebo-controlled trials of atypical antipsychotics in elderly patients with dementia-related psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Esophageal dysmotility/aspiration: Antipsychotic use has been associated with esophageal dysmotility and aspiration; use with caution in patients at risk of pneumonia (eg, Alzheimer's disease).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Extrapyramidal symptoms (EPS): May cause extrapyramidal symptoms, including pseudoparkinsonism, acute dystonic reactions, akathisia, and tardive dyskinesia (risk of these reactions is generally much lower relative to typical/conventional antipsychotics). Risk of dystonia (and probably other EPS) may be greater with increased doses, use of conventional antipsychotics, males, and younger patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Fever: Benign transient  temperature elevation (&gt;100.4&deg;F) may occur; peaking within the first 3 weeks of treatment. Rule out infection, agranulocytosis, and neuroleptic malignant syndrome (NMS) in patients presenting with fever.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperglycemia: Atypical antipsychotics have been associated with development of hyperglycemia; in some cases, may be extreme and associated with ketoacidosis, hyperosmolar coma, or death. Use with caution in patients with diabetes or other disorders of glucose regulation; monitor for worsening of glucose control. Patients with risk factors for diabetes should also be evaluated prior to therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myopericarditis: Myocarditis, pericarditis, pericardial effusion, cardiomyopathy, and HF have also been associated with clozapine.",
"     <b>",
"      [U.S. Boxed Warning]: Fatalities due to myocarditis have been reported; highest risk in the first month of therapy, however, later cases also reported.",
"     </b>",
"     Myocarditis or cardiomyopathy should be considered in patients who present with signs/symptoms of heart failure (dyspnea, fatigue, orthopnea, paroxysmal nocturnal dyspnea, peripheral edema), chest pain, palpitations, new electrocardiographic abnormalities (arrhythmias, ST-T wave abnormalities), or unexplained fever. Patients with tachycardia during the first month of therapy should be closely monitored for other signs of myocarditis. Discontinue clozapine if myocarditis is suspected; do not rechallenge in patients with clozapine-related myocarditis. The reported rate of myocarditis in clozapine-treated patients appears to be 17-322 times greater than in the general population. Clozapine should be discontinued in patients with confirmed cardiomyopathy unless benefit clearly outweighs risk.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Neuroleptic malignant syndrome (NMS): Use may  be associated with neuroleptic malignant syndrome (NMS); monitor for mental status changes, fever, muscle rigidity and/or autonomic instability.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Orthostatic hypotension:",
"     <b>",
"      [U.S. Boxed Warning]: May cause orthostatic hypotension (with or without syncope);",
"     </b>",
"     generally occurs more frequently with initial titration and in association with rapid dose increases. May be accompanied by respiratory and/or cardiac arrest. Use with caution in patients at risk of this effect or in those who would not tolerate transient hypotensive episodes (cerebrovascular disease, cardiovascular disease, hypovolemia, or concurrent medication use which may predispose to hypotension/bradycardia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; QT prolongation: Clozapine is associated with QT prolongation and ventricular arrhythmias including torsade de pointes; cardiac arrest and sudden death may occur. Use caution in patients with a history of long QT syndrome, conditions which may increase the risk of QT prolongation (cardiovascular disease, recent MI, uncompensated heart failure, clinically significant arrhythmias, family history of long QT syndrome) or concomitant use of medications known to prolong the QT interval. Hypokalemia and/or hypomagnesemia may increase the risk; correct electrolyte abnormalities prior to initiating therapy.  Discontinue clozapine if QT",
"     <sub>",
"      c",
"     </sub>",
"     interval &gt;500 msec.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sedation: May be moderate to highly sedating, use with caution in disorders where CNS depression is a feature; patients must be cautioned about performing tasks which require mental alertness (eg, operating machinery or driving). Use with caution in patients receiving general anesthesia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizures:",
"     <b>",
"      [U.S. Boxed Warning]: Seizures have been associated with clozapine use in a dose-dependent manner;",
"     </b>",
"     use with caution in patients at risk of seizures, including those with a history of seizures, head trauma, brain damage, alcoholism, or concurrent therapy with medications which may lower seizure threshold. Elderly patients may be at increased risk of seizures due to an increased prevalence of predisposing factors. Patients should be warned that a sudden loss of consciousness may occur with seizures.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Suicidal ideation: The possibility of a suicide attempt is inherent in psychotic illness or bipolar disorder; use with caution in high-risk patients during initiation of therapy. Prescriptions should be written for the smallest quantity consistent with good patient care.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tachycardia: May cause tachycardia (including sustained); sustained tachycardia is not limited to a reflex response to orthostatic hypotension, and is present in all positions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Temperature regulation: Impaired core body temperature regulation may occur; caution with strenuous exercise, heat exposure, dehydration, and concomitant medication possessing anticholinergic effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Thromboembolism: Rare cases of thromboembolism, including pulmonary embolism and stroke resulting in fatalities, have been associated with clozapine in patients with cardiovascular disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Weight gain: Significant weight gain has been observed with antipsychotic therapy; incidence varies with product. Monitor waist circumference and BMI.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease; gradually increase dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dementia:",
"     <b>",
"      [U.S. Boxed Warning]: Elderly patients with dementia-related psychosis treated with antipsychotics are at an increased risk of death compared to placebo.",
"     </b>",
"     Most deaths appeared to be either cardiovascular (eg, heart failure, sudden death) or infectious (eg, pneumonia) in nature. Clozapine is not approved for the treatment of dementia-related psychosis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glaucoma: Use with caution in patients with narrow-angle glaucoma;  condition may be exacerbated by cholinergic blockade. Screening is recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic disease or impairment; monitor hepatic function regularly. Hepatitis has been reported as a consequence of therapy. Discontinuation of therapy may be necessary with significant elevations in liver function tests; may reinitiate with close monitoring and if values return to normal.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis: Use with caution in patients with myasthenia gravis; condition may be exacerbated by cholinergic blockade.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pulmonary disease: Use with caution; gradually increase dose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Benzodiazepines: Concurrent use with  benzodiazepines may increase the risk of severe cardiopulmonary reactions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drugs metabolized by CYP enzymes: Clozapine is metabolized by CYP1A2, 2D6, and 3A4; use caution with medications which inhibit CYP activity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Drugs with QT prolongation potential: Use caution with other medications which may prolong the QT",
"     <sub>",
"      c",
"     </sub>",
"     interval (eg, some antipsychotic medications, some antibiotics, class 1a or III antiarrhythmics).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use in patients with dementia is associated with an increased risk of mortality and cerebrovascular accidents; avoid antipsychotic use for behavioral problems associated with dementia unless alternative nonpharmacologic therapies have failed and patient may harm self or others. In addition, use may cause or exacerbate syndrome of inappropriate antidiuretic hormone secretion or hyponatremia; monitor sodium closely with initiation or dosage adjustments in older adults. May also be inappropriate in older adults depending on comorbidities (eg, dementia, delirium) due to its potent anticholinergic effects   (Beers Criteria).  The elderly are more susceptible to adverse effects (including agranulocytosis, cardiovascular, anticholinergic, and tardive dyskinesia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Smokers: Clozapine levels may be lower in patients who smoke. Smoking cessation may cause toxicity in a patient stabilized on clozapine. Monitor change in smoking patterns.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Phenylalanine: FazaClo&reg; oral disintegrating tablets contain phenylalanine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Abrupt discontinuation: Medication should not be stopped abruptly; taper off over 1-2 weeks. If conditions warrant abrupt discontinuation (leukopenia, myocarditis, cardiomyopathy), monitor patient for psychosis and cholinergic rebound (headache, nausea, vomiting, diarrhea).",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F153989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (major), CYP2A6 (minor), CYP2C19 (minor), CYP2C9 (minor), CYP2D6 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C19 (weak), CYP2C9 (weak), CYP2D6 (moderate), CYP2E1 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F153921\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Abiraterone Acetate: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): May enhance the neurotoxic (central) effect of Antipsychotics. Severe extrapyramidal symptoms have occurred in some patients.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): CNS Depressants may enhance the CNS depressant effect of Alcohol (Ethyl).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: Antipsychotics may diminish the stimulatory effect of Amphetamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anti-Parkinson's Agents (Dopamine Agonist): Antipsychotics (Atypical) may diminish the therapeutic effect of Anti-Parkinson's Agents (Dopamine Agonist).  Management: Consider using an alternative antipsychotic agent when possible in patients with Parkinson's disease.  If an atypical antipsychotic is necessary, consider using clozapine or quetiapine, which may convey the lowest interaction risk.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Azelastine (Nasal): CNS Depressants may enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzodiazepines: May enhance the adverse/toxic effect of CloZAPine. Management: Consider decreasing the dose of (or possibly discontinuing) benzodiazepines prior to initiating clozapine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CarBAMazepine: May enhance the myelosuppressive effect of CloZAPine. CarBAMazepine may decrease the serum concentration of CloZAPine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May increase the serum concentration of CloZAPine. Management: Consider use of an alternative H2 antagonist. Monitor for increased toxic effects of clozapine if cimetidine is initiated/dose increased, or decreased effects if cimetidine is discontinued/dose decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the adverse/toxic effect of other CNS Depressants.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Codeine: CYP2D6 Inhibitors (Moderate) may diminish the therapeutic effect of Codeine. These CYP2D6 inhibitors may prevent the metabolic conversion of codeine to its active metabolite morphine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inducers (Strong): May increase the metabolism of CYP1A2 Substrates. Management: Consider an alternative for one of the interacting drugs. Some combinations may be specifically contraindicated. Consult appropriate manufacturer labeling.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Moderate): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP1A2 Inhibitors (Strong): May decrease the metabolism of CYP1A2 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2D6 Substrates: CYP2D6 Inhibitors (Moderate) may decrease the metabolism of CYP2D6 Substrates.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Tamoxifen.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cyproterone: May decrease the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Deferasirox: May increase the serum concentration of CYP1A2 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fesoterodine: CYP2D6 Inhibitors may increase serum concentrations of the active metabolite(s) of Fesoterodine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fosphenytoin: May decrease the serum concentration of CloZAPine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: Moderate Risk QTc-Prolonging Agents may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ivabradine: May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lithium formulations: May enhance the neurotoxic effect of Antipsychotics. Lithium formulations may decrease the serum concentration of Antipsychotics. Specifically noted with chlorpromazine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Macrolide Antibiotics: May decrease the metabolism of CloZAPine.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Azithromycin (Systemic); Fidaxomicin; Spiramycin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methylphenidate: Antipsychotics may enhance the adverse/toxic effect of Methylphenidate. Methylphenidate may enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoclopramide: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metoprolol: CYP2D6 Inhibitors may increase the serum concentration of Metoprolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: May enhance the QTc-prolonging effect of other Moderate Risk QTc-Prolonging Agents. Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Myelosuppressive Agents: May enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nebivolol: CYP2D6 Inhibitors (Moderate) may increase the serum concentration of Nebivolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nefazodone: May decrease the metabolism of CloZAPine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Omeprazole: May decrease the serum concentration of CloZAPine. Omeprazole may increase the serum concentration of CloZAPine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Phenytoin: May decrease the serum concentration of CloZAPine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying): May enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Quinagolide: Antipsychotics may diminish the therapeutic effect of Quinagolide.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May decrease the metabolism of CloZAPine.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin Modulators: Antipsychotics may enhance the serotonergic effect of Serotonin Modulators. This could result in serotonin syndrome.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tamoxifen: CYP2D6 Inhibitors (Moderate) may decrease serum concentrations of the active metabolite(s) of Tamoxifen. Specifically, CYP2D6 inhibitors may decrease the metabolic formation of highly potent active metabolites.  Management: Consider alternatives with less of an inhibitory effect on CYP2D6 activity when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tetrabenazine: May enhance the adverse/toxic effect of Antipsychotics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thioridazine: CYP2D6 Inhibitors may decrease the metabolism of Thioridazine.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F153948\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Herb/Nutraceutical: St John's wort may decrease clozapine levels. Avoid kava kava, gotu kola, valerian, St John's wort (may increase CNS depression).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F153923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F153938\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not seen in animal studies. Clozapine crosses the placenta and can be detected in the fetal blood and amniotic fluid (Barnas, 1994). Antipsychotic use during the third trimester of pregnancy has a risk for abnormal muscle movements (extrapyramidal symptoms [EPS]) and withdrawal symptoms in newborns following delivery. Symptoms in the newborn may include agitation, feeding disorder, hypertonia, hypotonia, respiratory distress, somnolence, and tremor; these effects may be self-limiting or require hospitalization. Healthcare providers are encouraged to enroll women 18-45 years of age exposed to clozapine during pregnancy in the Atypical Antipsychotics Pregnancy Registry (1-866-961-2388 or file://www.womensmentalhealth.org/pregnancyregistry). Women with amenorrhea associated with use of other antipsychotic agents may return to normal menstruation when switching to clozapine therapy. Reliable contraceptive measures should be employed by women of childbearing potential switching to clozapine therapy.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F153962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Enters breast milk/not recommended (AAP rates &ldquo;of concern&rdquo;; AAP 2001 update pending)",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F10912630\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Clozapine was found to accumulate in breast milk in concentrations higher than the maternal plasma (Barnas, 1994).",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F153939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to food. Some products may contain phenylalanine.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F153937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, orally-disintegrating",
"     </b>",
"     (CloZAPine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12.5 mg (100): $222.75",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (48): $143.89",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (48): $392.40",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablet, orally-disintegrating",
"     </b>",
"     (FazaClo Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12.5 mg (100): $247.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (48): $159.88",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (48): $436.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     150 mg (48): $517.73",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg (48): $690.30",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (CloZAPine Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (100): $131.94",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     50 mg (100): $165.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $341.86",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg (100): $632.32",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Clozaril Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25 mg (100): $417.94",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (100): $1082.89",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F153925\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     The Canadian labeling recommends initiating treatment in an inpatient setting or an outpatient setting with medical supervision and monitoring of vital signs for at least 6-8 hours after the first few doses.",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:2em;text-align:justify;\">",
"     Mental status, ECG, WBC (see below), vital signs, fasting lipid profile and fasting blood glucose/Hgb A",
"     <sub>",
"      1c",
"     </sub>",
"     (prior to treatment, at 3 months, then annually; liver function tests; BMI, personal/family history of obesity; waist circumference (weight should be assessed prior to treatment, at 4 weeks, 8 weeks, 12 weeks, and then at quarterly intervals. Consider titrating to a different antipsychotic agent for a weight gain &ge;5% of the initial weight); blood pressure; abnormal involuntary movement scale (AIMS).",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     WBC and ANC should be obtained at baseline and at least weekly for the first 6 months (26 weeks) of continuous treatment. If counts remain acceptable (WBC &ge;3500/mm",
"     <sup>",
"      3",
"     </sup>",
"     , ANC &ge;2000/mm",
"     <sup>",
"      3",
"     </sup>",
"     ) during this time period, then they may be monitored every other week for the next 6 months (26 weeks). If WBC/ANC continue to remain within these acceptable limits after the second 6 months (26 weeks) of therapy, monitoring can be decreased to every 4 weeks. If clozapine is discontinued, a weekly WBC should be conducted for an additional 4 weeks or until WBC is &ge;3500/mm",
"     <sup>",
"      3",
"     </sup>",
"     and ANC is &ge;2000/mm",
"     <sup>",
"      3",
"     </sup>",
"     . If clozapine therapy is interrupted due to moderate leukopenia, weekly WBC/ANC monitoring is required for 12 months in patients restarted on clozapine treatment. (",
"     <b>",
"      Note:",
"     </b>",
"     When therapy is interrupted for &gt;3 days, the Canadian labeling recommends weekly hematologic testing for an additional 6 weeks). If therapy is interrupted for reasons other than leukopenia/granulocytopenia, the 6-month time period for initiation of biweekly WBCs may need to be reset.",
"     <b>",
"      This determination depends upon the treatment duration, the length of the break in therapy, and whether or not an abnormal blood event occurred.",
"     </b>",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-right:0em;margin-top:2em;text-align:justify;\">",
"     Consult manufacturer prescribing information for determination of appropriate WBC/ANC monitoring interval.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F2869369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Anzapine (MY);",
"     </li>",
"     <li>",
"      Clopin (CH);",
"     </li>",
"     <li>",
"      Clopine (AU, ID, NZ, TW);",
"     </li>",
"     <li>",
"      Clopsine (EC, MX);",
"     </li>",
"     <li>",
"      Cloril (TH);",
"     </li>",
"     <li>",
"      Clozamed (TH);",
"     </li>",
"     <li>",
"      Clozarem (MY);",
"     </li>",
"     <li>",
"      Clozaril (AU, GB, HK, ID, IE, KP, MY, NZ, PK, SG, TH);",
"     </li>",
"     <li>",
"      Denzapine (GB, IE);",
"     </li>",
"     <li>",
"      Elcrit (DE);",
"     </li>",
"     <li>",
"      Ihope (PH);",
"     </li>",
"     <li>",
"      Lapenax (AR);",
"     </li>",
"     <li>",
"      Leponex (AE, AT, BE, BG, BH, BR, CH, CN, CO, CY, CZ, DE, DK, EE, EG, ES, FI, FR, GR, HN, IL, IQ, IR, IT, JO, KW, LB, LY, MX, NL, NO, OM, PE, PH, PL, PT, QA, SA, SE, SY, TR, UY, VE, YE);",
"     </li>",
"     <li>",
"      Lozapin (IN);",
"     </li>",
"     <li>",
"      Lozapine (IL);",
"     </li>",
"     <li>",
"      Luften (ID);",
"     </li>",
"     <li>",
"      Refraxol (PE);",
"     </li>",
"     <li>",
"      Sizopin (IN);",
"     </li>",
"     <li>",
"      Sizoril (ID);",
"     </li>",
"     <li>",
"      Syclop (PH);",
"     </li>",
"     <li>",
"      Tanyl (CO);",
"     </li>",
"     <li>",
"      Zapen (CO);",
"     </li>",
"     <li>",
"      Zapine (TW);",
"     </li>",
"     <li>",
"      Ziproc (PH)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F153915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Clozapine (dibenzodiazepine antipsychotic) exhibits weak antagonism of  D",
"     <sub>",
"      1",
"     </sub>",
"     , D",
"     <sub>",
"      2",
"     </sub>",
"     , D",
"     <sub>",
"      3",
"     </sub>",
"     , and D",
"     <sub>",
"      5",
"     </sub>",
"     dopamine receptor subtypes, but shows high affinity for D",
"     <sub>",
"      4",
"     </sub>",
"     ; in addition, it blocks the serotonin (5-HT",
"     <sub>",
"      2",
"     </sub>",
"     ), alpha-adrenergic, histamine H",
"     <sub>",
"      1",
"     </sub>",
"     , and cholinergic receptors",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F153934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 97% to serum proteins",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensively hepatic; forms metabolites with limited or no activity",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 50% to 60% (not affected by food)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Steady state: 12 hours (range: 4-66 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: 2.5 hours (range: 1-6 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~50%) and feces (30%) with trace amounts of unchanged drug",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Academy of Pediatrics Committee on Drugs, &ldquo;Transfer of Drugs and Other Chemicals Into Human Milk,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2001, 108(3):776-89.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/11533352/pubmed\" id=\"11533352\" target=\"_blank\">",
"        11533352",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Geriatrics Society 2012 Beers Criteria Update Expert Panel, \"American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,\"",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 2012, 60(4):616-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/22376048/pubmed\" id=\"22376048\" target=\"_blank\">",
"        22376048",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity, &ldquo;Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes,&rdquo;",
"      <i>",
"       Diabetes Care",
"      </i>",
"      , 2004, 27(2):596-601.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/14747245/pubmed\" id=\"14747245\" target=\"_blank\">",
"        14747245",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Anon, &ldquo;Clozapine and Myocarditis,&rdquo;",
"      <i>",
"       Aust Adv Drug React Bull",
"      </i>",
"      , 1994, 13:14-15.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Aronowitz JS, Safferman AZ, Lieberman JA, &ldquo;Management of Clozapine-Induced Enuresis,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 1995, 152(3):472.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Barnas C, Bergant A, Hummer M, et al, \"Clozapine Concentrations in Maternal and Fetal Plasma, Amniotic Fluid, and Breast Milk,\"",
"      <i>",
"       Am  J Psychiatry",
"      </i>",
"      , 1994, 151(6):945.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/8185013/pubmed\" id=\"8185013\" target=\"_blank\">",
"        8185013",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Campellone JV, McCluskey LF, and Greenspan D, &ldquo;Fatal Outcome From Neuroleptic Malignant Syndrome Associated With Clozapine,&rdquo;",
"      <i>",
"       Neuropsychiatry, Neuropsychology, and Behavioral Neurology",
"      </i>",
"      , 1995, 8:70-3.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Change in Clozapine Monitoring Requirements,&rdquo;",
"      <i>",
"       Pharm J",
"      </i>",
"      , 1995, 254:612.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Costello LE and Suppes T, &ldquo;A Clinically Significant Interaction Between Clozapine and Valproate,&rdquo;",
"      <i>",
"       J Clin Psychopharmacol",
"      </i>",
"      , 1995, 15(2):139-41.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/7782488/pubmed\" id=\"7782488\" target=\"_blank\">",
"        7782488",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dixon L, Perkins D, and Calmes C,",
"      <i>",
"       Guideline Watch (September 2009): Practice Guideline for the Treatment of Schizophrenia",
"      </i>",
"      , Arlington, Va: American Psychiatric Association, 2009. Available at file://www.psychiatryonline.com/content.aspx?aid=501001",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Foussias G and Remington G, &ldquo;Antipsychotics and Schizophrenia From Efficacy and Effectiveness to Clinical Decision-Making,&rdquo;",
"      <i>",
"       Can J Psychiatry",
"      </i>",
"      , 2010, 55(3):117-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/20370961/pubmed\" id=\"20370961\" target=\"_blank\">",
"        20370961",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Frazier JA, Gordon CT, McKenna K, et al, &ldquo;An Open Trial of Clozapine in 11 Adolescents With Childhood-Onset Schizophrenia,&rdquo;",
"      <i>",
"       J Am Acad Child Adolesc Psychiatry",
"      </i>",
"      , 1994, 33(5):658-63.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/8056728/pubmed\" id=\"8056728\" target=\"_blank\">",
"        8056728",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Funderberg LG, Vertrees JE, True JE, et al, &ldquo;Seizure Following Addition of Erythromycin to Clozapine Treatment,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 1994, 151(12):1840-1.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gerson SL and Meltzer H, &ldquo;Mechanisms of Clozapine-Induced Agranulocytosis,&rdquo;",
"      <i>",
"       Drug Saf",
"      </i>",
"      , 1992, 7(Suppl 1):17-25.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/1503673/pubmed\" id=\"1503673\" target=\"_blank\">",
"        1503673",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ghaeli P and Dufresne RL, &ldquo;Elevated Serum Triglycerides on Clozapine Resolve With Risperidone,&rdquo;",
"      <i>",
"       Pharmacotherapy",
"      </i>",
"      , 1995, 15:382.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gill SS, Bronskill SE, Normand SL, et al, &ldquo;Antipsychotic Drug Use and Mortality in Older Adults With Dementia,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2007, 146(11):775-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/17548409/pubmed\" id=\"17548409\" target=\"_blank\">",
"        17548409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hagg S, Spigset O, and Soderstrom TG, &ldquo;Association of Venous Thromboembolism and Clozapine,&rdquo;",
"      <i>",
"       Lancet",
"      </i>",
"      , 2000, 355(9210):1155-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/10791380/pubmed\" id=\"10791380\" target=\"_blank\">",
"        10791380",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kane J, Honigfeld G, Singer J, et al, &ldquo;Clozapine for the Treatment-Resistant Schizophrenic. A Double-Blind Comparison With Chlorpromazine,&rdquo;",
"      <i>",
"       Arch Gen Psychiatry",
"      </i>",
"      , 1988, 45(9):789-96.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/3046553/pubmed\" id=\"3046553\" target=\"_blank\">",
"        3046553",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kumra S, Frazier JA, Jacobsen LK, et al, &ldquo;Childhood-Onset Schizophrenia. A Double-Blind Clozapine-Haloperidol Comparison,&rdquo;",
"      <i>",
"       Arch Gen Psychiatry",
"      </i>",
"      , 1996, 53(12):1090-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/8956674/pubmed\" id=\"8956674\" target=\"_blank\">",
"        8956674",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lamberti JS, Olson D, Crilly JF, et al, \"Prevalence of the Metabolic Syndrome Among Patients Receiving Clozapine,\"",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2006, 163(7):1273-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/16816234/pubmed\" id=\"16816234\" target=\"_blank\">",
"        16816234",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lowe EJ and Ackman ML, &ldquo;Impact of Tobacco Smoking Cessation on Stable Clozapine or Olanzapine Treatment,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2010, 44(4):727-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/20233914/pubmed\" id=\"20233914\" target=\"_blank\">",
"        20233914",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Masi G and Milone A, &ldquo;Clozapine Treatment in an Adolescent With Bipolar Disorder,&rdquo;",
"      <i>",
"       Panminerva Med",
"      </i>",
"      , 1998, 40(3):254-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/9785928/pubmed\" id=\"9785928\" target=\"_blank\">",
"        9785928",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Meltzer HY, Alphs L, Green AI, et al, &ldquo;Clozapine Treatment for Suicidality in Schizophrenia: International Suicide Prevention Trial (InterSePT),&rdquo;",
"      <i>",
"       Arch Gen Psychiatry",
"      </i>",
"      , 2003, 60(1):82-91.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/12511175/pubmed\" id=\"12511175\" target=\"_blank\">",
"        12511175",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moore TA, &ldquo;Schizophrenia Treatment Guidelines in the United States,&rdquo;",
"      <i>",
"       Clin Schizophr Relat Psychoses",
"      </i>",
"      , 2011, 5(1):40-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/21459738/pubmed\" id=\"21459738\" target=\"_blank\">",
"        21459738",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Health and Clinical Excellence (NICE), National Collaborating Centre for Mental Health , &ldquo;Schizophrenia. Core Interventions in the Treatment and Management of Schizophrenia in Primary and Secondary Care (Updated),&rdquo; National Clinical Practice Guideline Number 82, 2009:1-399. Available at  www.nice.org.uk/cg082",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pacia SV and Devinsky O, &ldquo;Clozapine-Related Seizures: Experience With 5629 Patients,&rdquo;",
"      <i>",
"       Neurology",
"      </i>",
"      , 1994, 44(12):2247-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/7991106/pubmed\" id=\"7991106\" target=\"_blank\">",
"        7991106",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Peabody CA, Warner MD, Whiteford HA, et al, &ldquo;Neuroleptics and the Elderly,&rdquo;",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 1987, 35(3):233-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/2880887/pubmed\" id=\"2880887\" target=\"_blank\">",
"        2880887",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rabins PV, Blacker D, Rovner BW, et al, &ldquo;American Psychiatric Association Practice Guideline for the Treatment of Patients With Alzheimer's Disease and Other Dementias. Second Edition,&rdquo;",
"      <i>",
"       Am J Psychiatry",
"      </i>",
"      , 2007, 164(12 Suppl):5-56.  Available at file://psychiatryonline.org/guidelines.aspx",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/18340692/pubmed\" id=\"18340692\" target=\"_blank\">",
"        18340692",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Radford JM, Brown TM, and Borison RL, &ldquo;Unexpected Dystonia While Changing From Clozapine to Risperidone,&rdquo;",
"      <i>",
"       J Clin Psychopharmacol",
"      </i>",
"      , 1995, 15(3):225-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/7543499/pubmed\" id=\"7543499\" target=\"_blank\">",
"        7543499",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Risse SC and Barnes R, &ldquo;Pharmacologic Treatment of Agitation Associated With Dementia,&rdquo;",
"      <i>",
"       J Am Geriatr Soc",
"      </i>",
"      , 1986, 34(5):368-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/2870097/pubmed\" id=\"2870097\" target=\"_blank\">",
"        2870097",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Ronaldson KJ, Taylor AJ, Fitzgerald PB, et al, &ldquo;Diagnostic Characteristics of Clozapine-Induced Myocarditis Identified by an Analysis of 38 Cases and 47 Controls,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2010, 71(8):976-81.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/20361910/pubmed\" id=\"20361910\" target=\"_blank\">",
"        20361910",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Saltz BL, Woerner MG, Kane JM, et al, &ldquo;Prospective Study of Tardive Dyskinesia Incidence in the Elderly,&rdquo;",
"      <i>",
"       JAMA",
"      </i>",
"      , 1991, 266(17):2402-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/1681122/pubmed\" id=\"1681122\" target=\"_blank\">",
"        1681122",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Schneeweiss S, Setoguchi S, Brookhart A, et al, &ldquo;Risk of Death Associated With the Use of Conventional Versus Atypical Antipsychotic Drugs Among Elderly Patients,&rdquo;",
"      <i>",
"       CMAJ",
"      </i>",
"      , 2007, 176(5): 627-32.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/17325327/pubmed\" id=\"17325327\" target=\"_blank\">",
"        17325327",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Seifert RD, &ldquo;Therapeutic Drug Monitoring: Psychotropic Drugs,&rdquo;",
"      <i>",
"       J Pharm Pract",
"      </i>",
"      , 1984, 6:403-16.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Suppes T, Dennehy EB, Hirschfeld RMA, et al, &ldquo;The Texas Implementation of Medication Algorithms: Update to the Algorithms for the Treatment of Bipolar I Disorder,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 2005, 66(7):870-86.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/16013903/pubmed\" id=\"16013903\" target=\"_blank\">",
"        16013903",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Testani M Jr, &ldquo;Clozapine-Induced Orthostatic Hypotension Treated With Fludrocortisone,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 1994, 55(11):497-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/7989286/pubmed\" id=\"7989286\" target=\"_blank\">",
"        7989286",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Turetz M, Mozes T, Toren P, et al, &ldquo;An Open Trial of Clozapine in Neuroleptic-Resistant Childhood-Onset Schizophrenia,&rdquo;",
"      <i>",
"       Br J Psychiatry",
"      </i>",
"      , 1997, 170:507-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/9330014/pubmed\" id=\"9330014\" target=\"_blank\">",
"        9330014",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wickert WA, Campbell NR, and Martin L, &ldquo;Acute Severe Adverse Clozapine Reaction Resembling Systemic Lupus/Erythematosus,&rdquo;",
"      <i>",
"       Postgrad Med J",
"      </i>",
"      , 1994, 70(830):940-1.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wilson WH and Claussen AM, &ldquo;Seizures Associated With Clozapine Treatment in a State Hospital,&rdquo;",
"      <i>",
"       J Clin Psychiatry",
"      </i>",
"      , 1994, 55(5):184-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?34/21/35161/abstract-text/8071267/pubmed\" id=\"8071267\" target=\"_blank\">",
"        8071267",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9289 Version 50.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-110.170.48.130-F42F8ABDFE-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35161=[""].join("\n");
var outline_f34_21_35161=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708679\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153952\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153953\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153995\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153957\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153973\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153958\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15795891\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15795892\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F744545\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153928\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153912\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16156266\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11218426\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153932\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153931\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153991\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F154003\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153993\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153935\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153916\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153989\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153921\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153948\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153923\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153938\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153962\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10912630\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153939\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153937\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153925\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2869369\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153915\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153934\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9289\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9289|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?8/41/8854?source=related_link\">",
"      Clozapine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?13/31/13817?source=related_link\">",
"      Clozapine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f34_21_35162="Glomus tumor";
var content_f34_21_35162=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F77094%7EDERM%2F72924%7EDERM%2F61115%7EDERM%2F51899&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F77094%7EDERM%2F72924%7EDERM%2F61115%7EDERM%2F51899&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Glomus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 319px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A 13-year-old boy developed a painful nodule on his right great toe nail bed. Biopsy revealed a glomus tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Copyright &copy; Brovedani Piergiorgio, Dermatlas;",
"     <a href=\"file://www.dermatlas.org\" target=\"_blank\">",
"      file://www.dermatlas.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual glomus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bluish-red flush of the nail induced by a glomus tumor of the nail bed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual glomus tumor",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Left: Red flush of the nail bed induced by a subungual glomus tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Subungual glomus tumor with nail dystrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Nail dystrophy caused by a subungual glomus tumor. The red subungual patch indicates the location of the tumor.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35162=[""].join("\n");
var outline_f34_21_35162=null;
var title_f34_21_35163="Exercise Rx growing pains";
var content_f34_21_35163=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66815&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Muscle stretching regimen for growing pains in children*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Quadriceps",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Patient prone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Flex heel to buttock and hold",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lift thigh off table to stretch",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hamstrings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Patient supine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lift leg by heel",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Hold knee straight",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Flex hip to stretch",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Calf",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Patient prone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Knee flexed to 90 degrees",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Push foot down to stretch",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Patient supine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Knee straignt",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Push foot up to stretch",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Regimen to be performed by parents twice per day. Each stretch is held for 10 to 20 seconds and repeated 10 to 20 times for each leg.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Baxter, MP, Dulberg, C. \"Growing pains\" in childhood--a proposal for treatment. J Pediatr Orthop 1988; 8:402.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35163=[""].join("\n");
var outline_f34_21_35163=null;
var title_f34_21_35164="ADA lipid guideline";
var content_f34_21_35164=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75008&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75008&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Management of dyslipidemia in children and adolescents with diabetes",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Screening",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Type 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Obtain lipid profile at diagnosis (after glycemic control is well established). If normal, repeat every 5 years.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &bull; Begin at age 10 years (or onset of puberty, if earlier)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        &bull; Begin prior to age 10 years if there is a family history of early cardiovascular disease, or if child is overweight or obese",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Type 2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Obtain lipid profile at diagnosis (after glycemic control is well established). If normal, repeat every 2 years.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Monitoring",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        If lipids are abnormal, annual monitoring is recommended",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        If LDL cholesterol values are within the accepted risk levels (&lt;100 mg/dL [2.6 mmoL/L]), a lipid profile should be repeated every 5 years for type 1 diabetes, or every 2 years for type 2 diabetes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Goals",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LDL &lt;100 mg/dL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HDL &gt;35 mg/dL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Triglycerides &lt;150 mg/dL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment strategies",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diet: Step 2 AHA diet, aimed to decrease intake of saturated fat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Maximize glycemic control",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Weight reduction, if indicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Indications: Age &gt;10 years AND LDL &ge;160 mg/dL, OR LDL 130-159 mg/dL if other risk factors for CVD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Statins &plusmn; resins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Fibric acid derivatives if triglycerides &gt;1000 mg/dL",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Manage other CVD risk factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Blood pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tobacco",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Obesity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Inactivity",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LDL: low-density lipoprotein; HDL: high-density lipoprotein; CVD: cardiovascular disease; AHA: American Heart Association.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: American Diabetes Association. Management of dyslipidemia in children and adolescents with diabetes. Diabetes Care 2003; 26:2194. Copyright &copy; 2003 American Diabetes Association. Modified based on 2008 ADA guidelines.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35164=[""].join("\n");
var outline_f34_21_35164=null;
var title_f34_21_35165="Contents: Endocrinology calculators";
var content_f34_21_35165=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?1/56/1934\">",
"       Endocrinology and Diabetes",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Endocrinology calculators",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Endocrinology calculators",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Medical Equations",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/41/40593\">",
"           Calculator: Body mass index (BMI; Quetelet's index)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/47/37630\">",
"           Calculator: Body mass index for adults (Metric, Patient information)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/23/42366\">",
"           Calculator: Body mass index for adults (Patient information)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/35/17969\">",
"           Calculator: Calcium correction in hypoalbuminemia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/51/15153\">",
"           Calculator: Calcium correction in hypoalbuminemia (SI units)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/54/13153\">",
"           Calculator: Glycemic assessment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/26/29089\">",
"           Calculator: Lean body weight (adult female)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/21/29009\">",
"           Calculator: Lean body weight (adult male)",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-3537154482-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f34_21_35165=[""].join("\n");
var outline_f34_21_35165=null;
var title_f34_21_35166="Budding yeast Gram stain";
var content_f34_21_35166=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F70812&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F70812&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Skin scraping in disseminated candidiasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A budding yeast (arrow) is visible in this Gram stain of a pustular skin lesion from a neutropenic patient.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol A Kauffman, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35166=[""].join("\n");
var outline_f34_21_35166=null;
var title_f34_21_35167="Rib fracture stabilization";
var content_f34_21_35167=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F73486&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F73486&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rib fracture stabilization",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest X-ray showing internal fixation of multiple left rib fractures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f34_21_35167=[""].join("\n");
var outline_f34_21_35167=null;
